Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections.
AUTOR(ES)
McGeorge, M B
RESUMO
Pretreatment of mice intraperitoneally with silica, trypan blue, or dextran sulfate to inhibit macrophage function markedly increased the lethality of a systemic intravenous infection with herpes simplex virus type 2, but did not affect the lethality or local virus growth after vaginal infection of mice with herpes simplex virus type 2. Agents which inhibit macrophage function by different mechanisms decreased host resistance to herpes simplex virus type 2, but the effects of macrophage-inhibitory agents may vary according to the route of virus infection.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=422201Documentos Relacionados
- Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections.
- Herpes simplex infections.
- Cutaneous herpes simplex infections.
- Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections.
- Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.
